Related references
Note: Only part of the references are listed.Awareness of, and Compliance with, Domperidone Revised Labeling After a Risk-Minimization Activity in Europe
Daniel Fife et al.
CLINICAL DRUG INVESTIGATION (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Transporters
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes
Stephen P. H. Alexander et al.
BRITISH JOURNAL OF PHARMACOLOGY (2019)
Impact of safety warnings on domperidone prescribing in Ireland
M. Teeling et al.
IRISH JOURNAL OF MEDICAL SCIENCE (2018)
Domperidone for increasing breast milk volume in mothers expressing breast milk for their preterm infants: a systematic review and meta-analysis
L. E. Grzeskowiak et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2018)
A meta-analysis on the cardiac safety profile of domperidone compared to metoclopramide
Serhat Bor et al.
UNITED EUROPEAN GASTROENTEROLOGY JOURNAL (2018)
Domperidone and Risk of Ventricular Arrhythmia and Cardiac Death: A Systematic Review and Meta-analysis
Nattawut Leelakanok et al.
CLINICAL DRUG INVESTIGATION (2016)
Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology
Jesper Hallas et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2016)
Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease
Christel Renoux et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
The association between domperidone and ventricular arrhythmia in the postpartum period
Kate Smolina et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2016)
Domperidone Prescribing Practices Exposed Patients to Cardiac Risk despite a Black Box Warning: A Canadian Tertiary Care Center Study
Nauzer Forbes et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2016)
Risk of Out-of-Hospital Sudden Cardiac Death in Users of Domperidone, Proton Pump Inhibitors, or Metoclopramide: A Population-Based Nested Case-Control Study
Alejandro Arana et al.
DRUG SAFETY (2015)
Active-comparator design and new-user design in observational studies
Kazuki Yoshida et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Domperidone, cytochrome P450 3A4 isoenzyme inhibitors and ventricular arrhythmia: a nationwide case-crossover study
Hung-Lin Chen et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2015)
Factors Affecting the Occurrence of Out-of-Hospital Sudden Cardiac Arrest
Izabella Uchmanowicz et al.
EMERGENCY MEDICINE INTERNATIONAL (2015)
Testing the Newcastle Ottawa Scale showed low reliability between individual reviewers
Lisa Hartling et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2013)
Domperidone in Parkinson's Disease: A Perilous Arrhythmogenic or the Gold Standard?
Unax Lertxundi et al.
CURRENT DRUG SAFETY (2013)
Bias in Observational Studies of Prevalent Users: Lessons for Comparative Effectiveness Research From a Meta-Analysis of Statins
Goodarz Danaei et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
Case-control studies: basic concepts
Jan P. Vandenbroucke et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2012)
Drug-Induced Parkinsonism
Hae-Won Shin et al.
JOURNAL OF CLINICAL NEUROLOGY (2012)
Time-window Bias in Case-control Studies
Samy Suissa et al.
EPIDEMIOLOGY (2011)
GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables
Gordon Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Domperidone and Ventricular Arrhythmia or Sudden Cardiac Death A Population-Based Case-Control Study in the Netherlands
Charlotte van Noord et al.
DRUG SAFETY (2010)
Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses
Andreas Stang
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Sudden cardiac death: epidemiology and risk factors
A. Selcuk Adabag et al.
NATURE REVIEWS CARDIOLOGY (2010)
Risk of serious ventricular arrhythmia and sudden cardiac death in a cohort of users of domperidone: a nested case-control study
Catherine B. Johannes et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2010)
Sudden death in patients receiving drugs tending to prolong the QT interval
Kate Jolly et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Ventricular Tachycardia and Sudden Cardiac Death
Bruce A. Koplan et al.
MAYO CLINIC PROCEEDINGS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Domperidone: Review of pharmacology and clinical applications in gastroenterology
Savio C. Reddymasu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Non-cardiac QTc-prolonging drugs and the risk of sudden cardiac death
SMJM Straus et al.
EUROPEAN HEART JOURNAL (2005)
Induced QT prolongation and torsades de pointes
YG Yap et al.
HEART (2003)
Evaluating medication effects outside of clinical trials: New-user designs
WA Ray
AMERICAN JOURNAL OF EPIDEMIOLOGY (2003)
Domperidone should not be considered a no-risk alternative to cisapride in the treatment of gastrointestinal motility disorders
B Drolet et al.
CIRCULATION (2000)
Share Paper
